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Background: The prognosis of hyperventilation syndrome (HVS) is generally good. However, it is important to
proceed with care when treating HVS because cases of death following hyperventilation have been reported. This
paper was done to demonstrate the clinical risk of post-hyperventilation apnea (PHA) in patients with HVS.
Case presentation: We treated two patients with HVS who suffered from PHA. The first, a 21-year-old woman, had
a maximum duration of PHA of about 3.5 minutes and an oxygen saturation (SpO2) level of 60%. The second
patient, a 22-year-old woman, had a maximum duration of PHA of about 3 minutes and an SpO2 level of 66%. Both
patients had loss of consciousness and cyanosis. Because there is no widely accepted regimen for treating patients
with prolonged PHA related to HVS, we administered artificial ventilation to both patients using a bag mask and
both recovered without any after effects.
Conclusion: These cases show that some patients with HVS develop prolonged PHA or severe hypoxia, which has
been shown to lead to death in some cases. Proper treatment must be given to patients with HVS who develop
PHA to protect against this possibility. If prolonged PHA or severe hypoxemia arises, respiratory assistance using a
bag mask must be done immediately.
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Hyperventilation syndrome (HVS) is characterized by
functional hyperventilation attacks with no underlying
organic abnormality. In Japan, 508 patients with acute
HVS were reported to range in age from 5–85 years,
and acute HVS was particularly prevalent among women
in their late teens and among men in their twenties [1].
The male-to-female ratio is 3 to 7 [1]. HVS is also related
to psychosomatic stressors. HVS patients show various
clinical symptoms such as anxiety, dyspnea, hypocapnia,
tetany, and unconsciousness.
Traditionally, it has been considered that hyperventila-
tion attacks spontaneously disappear and that the paper-
bag method or the administration of anxiolytic agents
leads to the disappearance of such attacks regardless of
their severity. However, there is little evidence regarding
the use of the paper-bag method for HVS and the* Correspondence: munemoto8214@jkajyo.ac.jp
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distribution, and reproduction in any mediumincidence of death, severe hypoxia, or myocardial infarc-
tion in association with the paper-bag method [2].
Recently, the paper-bag method was not recommended
for the treatment of patients with HVS [2].
We have experienced several patients with HVS who
had post-hyperventilation apnea(PHA). PHA is apnea that
follows hyperventilation due to HVS or another cause.
In most cases, the patient spontaneously recovered from
PHA within one minute without any clinical problems.
Moreover, we recently encountered two patients with
HVS in whom PHA persisted with cyanosis, hypoxemia,
and loss of consciousness for more than three minutes.
We were confronted with difficult decisions as to whether
or not to perform cardiopulmonary resuscitation (CPR)
on these patients.
Previously, Haldane and Douglas reported PHA in
humans [3,4]. Some studies have indicated experimental
PHA in healthy adults [5,6]. According to several studies,
PHA is frequent in patients with central nervous ab-
normalities [7,8], can be complicated by lung disease
(pulmonary emphysema, bronchial asthma) [9,10], and led
to the death of one patient [9]. Few studies have reportedtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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[11], MacDonald [12], and Chin [13] reported PHA with
hypoxemia related to HVS. However, aside from
MacDonald’s case, there are few previous case reports of
HVS patients who were rescued from PHA after having
long term PHA accompanied by cyanosis, hypoxemia, and
loss of consciousness. Here we present two patients with
HVS who developed prolonged PHA. In analyzing these
cases, the risk of prolonged PHA and the possible treat-
ment for hyperventilation attack were examined. The aim
of this report is to demonstrate the development and




The patient was a 21-year-old woman. At the age of
18 years, she suffered a hyperventilation attack following
stressors at her nursing school. Her strongest stressor
was practicing as a nurse at the hospital. She was sub-
sequently hospitalized several times for frequent hyper-
ventilation attacks. There were no organic abnormalities
according to several medical examinations including a
blood test, chest X-ray, electrocardiogram, electro-
encephalogram and head CT. She was diagnosed with
HVS. Her hyperventilation attacks gradually decreased
in response to the paper-bag method or anxiolytic agents
administered during hospitalization. For approximately
one year after being discharged from the hospital, no
attacks occurred. However, the hyperventilation attacks
recurred when triggered by acute tonsillitis. Because of
the frequent attacks she was referred to our hospital to
undergo a regimen of psychotherapy and fasting therapy
[14,15], which is effective for various stress-related
diseases. Immediately on hospitalization, she developed
frequent hyperventilation attacks.
Patient 2
The patient was a 22-year-old woman. At the age of
21 years, she suffered from affective disorder following
sexual harassment in her office. Her symptoms were
relieved by antidepressants and counseling. However,
she was admitted to our hospital for relapse, which
might have been caused by her stopping taking the
medication without consulting the attending physician.
After her admission, she began to improve. About one
month after admission, a visit from one of her coworkers
reminded her of several episodes of sexual harassment,
and her emotional state became unstable. She then
developed hyperventilation attacks for the first time.
Clinical profiles of the patients
There was no medical/family history of bronchial asthma
or epilepsy for either patient. On admission, the bodymass index (BMI) values of patients 1 and 2 were 20.1 and
17.8, respectively. We performed several medical examina-
tions, such as blood tests, chest X-ray, echocardiogram,
electrocardiogram, and cephalic CT, to rule out organic
diseases that could cause hyperventilation. There were no
abnormalities in the blood test results of either patient
(WBC: 4800/μL and 5200/μL, Hb: 13.1 g/dL and 11.3 g/dL,
platelet: 20.1 × 104/μL and 28.9 × 104/μL, AST: 23 IU/L
and 18, ALT: 13 IU/L and 17 IU/L,s-AMY: 66 IU/L and
97 IU/L,CRP: none and o.1 mg/dL, creatinine: 0.7 mg/dL
and o.9 mg/dL, Na: 143 mEq/L and 141 mEq/L, K:
3.9 mEq/L and 4.3 mEq/L, fT4: 1.2 ng/dL and i.0 ng/dL,
fT3: 1.2 pg/dL and 3.3 pg/dL,TSH: 0.41 μIU/mL and
1.08 μIU/mL). There were no abnormal findings in the
chest X-ray, electrocardiogram, echocardiogram, or ceph-
alic CT, so lung, heart and brain disease were ruled out. A
hyperventilation attack was identified based on respiration
that obviously exceeded the usual breathing rate (about 12
to 20 breaths per minute) and clinical symptoms such as
tetany. A physician used a stethoscope to confirm that
there were no airway stenosis sounds or abnormal alveolar
sounds. We could not analyze arterial blood-gas to
prove hypocapnia because the hospital did not possess
the device needed to perform this analysis. Neither pa-
tient presented with hypoxemia during the hyperventi-
lation attacks or normal respiration. Therefore, the
possibility of a hyperventilation attack being caused by
other disorders was ruled out. Although the arterial PCO2
level was not measured for either patient, the clinical
presentation left little doubt that over-breathing resulted
in HVS. To examine the psychological aspects, the
Minnesota multiphasic personality inventory(MMPI)was
performed. The MMPI showed high scores of Hs: 30,
D: 48 and Hy: 33 for Patient 1 and Sc: 54, Pt: 49 and D:35
for Patient 2. These data suggest a depressive state for
both patients, namely anxiety about her physical symp-
toms by Patient 1 and unreasonable fears or anxiety and
obsessions by Patient 2. In both patients, some stressors
were present prior to the hyperventilation attacks. In case
1, acute tonsillitis induced the hyperventilation attacks,
which occurred frequently and increased her anxiety level.
Immediately on hospitalization, she developed frequent
hyperventilation attacks before fasting therapy [14,15] was
begun. She agreed to undergo fasting therapy but had
considerable anxiety over receiving the therapy. Hos-
pitalization and anxiety about the fasting therapy became
the stressors and triggers of her hyperventilation attacks
after admission to the hospital. In case 2, a co-worker’s
visit to her in the hospital evoked memories of the
sexual harassment in the office and induced hy-
perventilation attacks. Both cases were diagnosed with
HVS because they had preceding stressors and no
organic abnormalities that could cause hyperventila-
tion attacks.
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Figure 1 shows a series of hyperventilation attacks by
Patient 1 on the fifth day after admission. PHA persisted
for 3.5 minutes, and oxygen saturation (SpO2) decreased
to 60%. Cyanosis of the lips and nail beds developed.
She did not respond to pain stimulation. Loss of con-
sciousness was observed, and spontaneous respiration
did not start again. Therefore, artificial respiration was
initiated by the bag mask method. After a few minutes,
spontaneous respiration started again. Then, an ad-
ditional hyperventilation attack occurred, followed by
apnea for two minutes. Simultaneously, cyanosis of the
lips developed, and SpO2 decreased to 70%. Artificial
respiration with a bag mask was performed, and after a
few minutes, spontaneous respiration started again. The
series of attacks ended.
The course of PHA in Patient 2 is shown in Figure 2.
After a 30-minute hyperventilation attack, apnea persis-
ted for two minutes, causing the lips to become cyanotic
and SpO2 to decrease to 72%. Spontaneous respiration
re-started without treatment. However, after a few
minutes, additional PHA for 3 minutes and cyanosis of
the lips and face were observed. SpO2 was 66%. Even
after three minutes, respiration did not start again, and
artificial respiration with a bag mask was induced. A few
minutes later, spontaneous respiration started again.
Hyperventilation attacks then occurred repeatedly. To
treat the initial hyperventilation attack, 10 mg diazepam
was intramuscularly administered by dividing the dose
into two boluses to prevent apnea. To treat the subse-
quent hyperventilation attack, 2.5 mg haloperidol was
intramuscularly administered.
SpO2 was measured with a pulse oximeter (NIHON
KOHDEN, SAT-2100 with finger probe). The physician
measured the SpO2 of the patients several times during















Figure 1 Clinical course of apnea and HV attacks on fifth day after ad
apnea after an HV attack with a minimum SpO2 of 60% and cyanosis of the
HV attack or during normal respiration. X1 and X3 represent the apneic star
bag-mask. X1X2 and X3X4 are the lengths of the apneic times, which were
times X1, X2, X3, and X4 were not recorded correctly. HV: hyperventilation.ventilation, SpO2 and recorded minimum SpO2 were
frequently measured during PHA. Because the pulse
oximeter could not save the measured SpO2 data, not all
of the data were saved.
The respiratory rate (RR) is defined as the number of
breaths per minute. The RR was measured at least one
time during hyperventilation. PHA was identified based
on the absence of breath sounds at auscultation and the
absence of wall motion of the chest. RR and length of
PHA were measured by a nurse, following the physi-
cian’s directions. Loss of consciousness was determined
based on the absence of response to painful stimuli to
the sternum and the absence of response to calling.
Cyanosis was determined by the physician’s inspection
of the skin of the patients.
Discussion
We experienced two patients with HVS who showed
prolonged PHA with hypoxemia, cyanosis, and loss of
consciousness. There have been many reports of PHA,
but few clinical reports of prolonged PHA have been
made. Though the risk of death is present for patients
with HVS who present severe hypoxemia following
prolonged PHA, no management strategy for patients
with extended PHA has been established. In this report
we demonstrated the treatment course of patients with
HVS who had prolonged PHA with severe hypoxemia
and discussed the mechanism, risk of death, and man-
agement of PHA.
PHA and BHS
As described above, only a few studies have reported
PHA related to HVS. Inagaki et al. and MacDonald et al.
have reported PHA related to HVS during adolescence
or young adulthood. Inagaki’s cases were a 17-year-old
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mission: Patient 1. The patient presented a 3.5-minute episode of
lips and nail beds. The patient did not exhibit hypoxemia during the
ting time. X2 and X4 represent the time of the assisted ventilation by
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Figure 2 Clinical course of apnea and HV attacks about one month after admission: Patient 2. The patient presented a 3-minute episode
of apnea after an HV attack with a minimum SpO2 of 66% and cyanosis of the lips. The patient did not show hypoxemia during the
hyperventilation attack or during normal respiration. HV: hyperventilation, I.m.: intramuscular injection.
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children is a disease entity resembling PHA, and a
common disease in infants. BHS causes apnea, cyanosis,
pale face, and loss of consciousness following crying
induced by pain, anger and fear. The patient sponta-
neously recovers. BHS resembles PHA in terms of the
development of apnea after hyperventilation. PHA and
BHS differ in the age of onset. MacDonald’s case was a
14-year-old girl [12]. The mechanism of BHS is associated
with various physiological (dysregulation of vagal nerve,
anemia, etc.) and psychological (infant crying induced by
pain, anger, and fear) factors [16,17]. One fatality was
reported [18].Prolonged PHA and Hypoxemia
In Inagaki and MacDonald’s patients, cyanosis and hyp-
oxemia were observed. PHA in Inagaki’s cases persisted
for one to two minutes, resulting in spontaneous recov-
ery [11]. PHA in MacDonald’s patient persisted for three
minutes and showed a minimum PaO2 of 25 mmHg.
Therefore, intratracheal intubation with an artificial res-
pirator was performed for respiration control [12].
MacDonald’s case was reported as an example of a near-
fatal instance of PHA. Chin reported hypoxemia and
PHA in patients with HVS [13]. Three patients pre-
sented PHA, and their SaO2 levels were 48%, 63%, and
68%. The SaO2 of four patients ranged from 71% to 81%.
The PaO2 of five patients ranged from 32 torr to 64 torr.
In our patients, PHA persisted for three minutes or
more in the presence of cyanosis, hypoxemia, and loss of
consciousness (minimum SpO2: 60% and 66%, respec-
tively). Immediately, artificial respiration with a bag
mask was administered, and respiration recovery was
soon achieved. Our cases were serious and presented
long durations of PHA related to HVS.Mechanism of PHA
The phenomenon of PHA has been observed by many
researchers. PHA has been reported to be due to a
decreased PaCO2 [3,19] and has been reported to be
induced when PaCO2 was reduced to the threshold
[20,21]. Hypocapnia caused by hyperventilation presents
the condition of alkalosis. In alkalosis, reduced hydrogen
ions [H+] acting on the chemoreceptors lead to the
suppression of breathing [20].
Even if hypocapnia after hyperventilation is norma-
lized, the stimuli to begin breathing do not immediately
restart, because the threshold level of PaCO2 is elevated
[22]. This seems likely to be associated with persisting
hypocapnia in the brain, even when arterial and alveolar
PaCO2 are normalized. Cummin et al. [23] demonstrated
by a mathematical simulation that central chemorecep-
tor PCO2 recovered more slowly than arterial PaCO2. In
addition, reduced vigilance after hyperventilation seems to
be related to the appearance of PHA according to Mangin
et al. [8]. They reported that post-hyperventilation sleep
reduces central neural facilitations, allowing the lack of
chemical stimulation to induce apnea [8]. These studies
may explain the mechanism of PHA.
While the prolongation of PHA seems to be closely
linked to the duration of a hyperventilation attack [24],
Meah et al. reported that, conversely, the length of PHA
was independent of the length of the hyperventilation at-
tack [6]. The hypoxic ventilatory drive is attenuated at
hypocapnia due to the hyperventilation attack [25,26],
which might reduce breathing stimulation and elongate
PHA even during hypoxia. This might worsen hypo-
xemia. Also, this is regarded as one of the mechanisms
of post-hyperventilation hypoxemia. Other mechanisms
of post-hyperventilation hypoxemia include a lack of
oxygen intake during prolonged PHA. In addition,
because the oxygen stores in the body are far lower than
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dioxide after a hyperventilation attack would lead to
hypoxemia more rapidly than PaCO2 would rise [27].
Furthermore, Nolan et al. demonstrated that post-
hyperventilation hypoxemia was due to the alteration of
pulmonary blood flow distribution, causing a drop in the
V/Q ratio [28]. It was reported that post-hyperventila-
tion hypoxemia might be dependent on the severity of
the hypocapnia [29].
We thought that the prolongation of PHA of our
patients might be due to several factors, such as the
delay of PCO2 recovery in the central chemoreceptor,
long hyperpnoea, and unconsciousness during PHA. As
for post-hyperventilation hypoxemia with cyanosis, a
lack of oxygen intake caused by long PHA, the attenuation
of the hypoxic ventilator drive, a lower oxygen store, and
alteration of the pulmonary blood flow distribution might
have played an important role. In case 2, we cannot deny
the possibility that diazepam might have participated in
the respiratory depression to a certain extent.
Drug prescription of Diazepam
Although diazepam has a risk of respiratory inhibition,
we divided its administration into two boluses to prevent
apnea. The 10 mg of total diazepam was not an over-
dose. We assume that the 10 mg of diazepam partially
contributed to the apnea, but was not the only factor.
Diazepam is a long-acting antianxiety sedative and can
cause respiratory depression [30]. A standard dose of
diazepam is considered to be 0.25 ~ 0.30 mg/kg (intra-
venous administration) [25,31]. The initial dose of diaze-
pam administered to patient 2 was 5 mg (0.11 mg/kg),
and a dose of 5 mg was added about 30 minutes later.
The total dosage of 10 mg (0.22 mg/kg) was not exces-
sive compared with the standard dosage. In addition, we
administered the diazepam by intramuscular injection,
which was expected to act gradually. We believe that
our means of administration of diazepam was proper to
prevent respiratory depression or apnea. However it is
possible that the diazepam might have participated
partially in the prolonged PHA of patient 2, because the
effectiveness of diazepam varies greatly from person to
person. However, we cannot identify the degree to which
diazepam was a factor in the PHA. Therefore, diazepam
should be chosen very carefully to prevent prolonged
PHA and cyanosis in the treatment of hyperventilation
attacks related to HVS.
Risk of PHA
It remains to be clarified whether or not PHA related to
HVS in humans can be fatal. However, some studies
have identified related issues.
MacDonald reported a near-fatal case of PHA related
to HVS [12]. The patient was successfully treated withintubation and ventilation. Chin et al. reported cases
with HVS that presented long PHA and severe hypo-
xemia [13]. The treatments administered to the patients
were not mentioned.
In experiments on animals, the potential lethal effect
of PHA was reported by Mosso [32,33] when he
hyperventilated nine dogs. After hyperventilation, five of
the dogs were left entirely undisturbed to either die
apneic or to recover unaided. Two dogs died. The degree
of hypoxia observed was striking. At the beginning of
their experiment, the arterial oxygen content was 14.8
volume percent and the arterial carbon dioxide content
was 16.2 volume percent. At the end of eight minutes of
apnea, the arterial oxygen content was zero, and the
arterial carbon dioxide content was 21.7 volume percent.
Based on the above findings, we cannot deny the possibi-
lity that PHA related to HVS can lead to a fatal outcome.
Comment about the treatment of HVS
Although HVS is generally reversible and shows a good
prognosis, its treatment should be administered with
care, because post-hyperventilation apneic cases or other
cases that resulted in death [2,34] have been reported.
As mentioned above, there is a risk of death, especially
in prolonged PHA related to HVS. We should assume
that some patients with HVS could develop PHA or
post-hyperventilation hypoxia with cyanosis. It is not
clear whether PHA related to HVS can be fatal or not,
but emergency treatment such as CPR should always be
available considering the possibility of a fatal outcome.
We propose that respiratory assistance by bag mask
should be performed for critical situations in PHA with
hypoxemia, while blood–gas analysis and the monitoring
of SpO2 and other vital signs such as heart rate, blood
pressure, etc., should be performed. It is desirable that a
proper amount of oxygen be given to the patient,
because hypoxemia is not good for the brain and hypo-
xemia at hypocapnia does not stimulate respiration. Also
we should be very careful about using sedatives such as
diazepam, which can cause respiratory depression, to stop
a hyperventilation attack, because we cannot exclude the
possibility that they will induce PHA. It is a traditional
practice to treat hyperventilation attacks related to HVS
by paper-bag rebreathing. However the paper-bag method
seems to be a potentially risky procedure, as death,
hypoxia and collapse have been reported to occur with
paper-bag rebreathing [2]. Furthermore, the effectiveness
of the paper-bag method is not clear. Thus, paper-bag
rebreathing should not be used in hyperventilation
attacks.
Limitations of report
Although we believe that this report provides clinically
important and useful information about PHA and HVS,
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evaluate the pulmonary and breathing functions. This
report is retrospective and it was not possible to collect
all necessary data. Particularly, it was unfortunate that
we could not analyze the arterial blood-gas of patients in
order to accurately evaluate PaCO2, PH, and PaO2,
which demonstrate hypocapnia or hypoxemia. Also,
continuous monitoring of the breathing rate and oxygen
saturation to evaluate and examine the hyperpnoea and
the PHA was not possible. These problems were
encountered with regard to the diagnosis of HVS and to
the study of the mechanism and treatment of PHA.
However, the diagnosis of HVS was based on clinical
findings and other medical examinations, and conse-
quently we have no doubt that HVS was correctly diag-
nosed. To study PHA related with HVS, physicians
should prepare a system of objective data collection to
evaluate the pulmonary and breathing functions, because
the opportunities to encounter PHA caused by HVS are
limited.
Conclusion
These cases show that some patients with HVS develop
prolonged PHA or severe hypoxia, which is believed to be
potentially risky based on its lethality in some cases.
Proper emergency treatment should be available for
patients with HVS who develop PHA. If prolonged PHA
or severe hypoxemia arises, it is necessary to immediately
perform respiratory assistance by bag mask as a precau-
tionary measure.
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